Joseph Klein III, Director at IONIS PHARMACEUTICALS INC (IONS), sold 2,000 shares at $46.15 ($92K) on 2018-03-29, disclosed to the SEC on 2018-03-30.
Open-market sale of $92k IONS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IONS | SELL | 2026-04-02 | $1.7M | — | Filing → |
| IONS | SELL | 2026-03-05 | $3.4M | — | Filing → |
| IONS | SELL | 2025-11-28 | $320K | — | Filing → |